The Division of Clinical Therapeutics is committed to understanding the mechanisms underlying anxiety, mood, eating and related psychiatric disorders and to improving methods to treat them. Current investigations include treatment of unipolar and bipolar depressive disorders, of a range of anxiety disorders and eating disorders, of smoking cessation, of hypochondriasis, of psychiatric symptoms following Lyme disease, and of fatigue associated with HIV. A variety of techniques are being applied to uncover psychological, biological, genetic, and environmental factors that contribute to the development and persistence of these serious psychiatric problems. These include brain imagining, molecular genetics, and neuropsychological testing. Treatment trials using both medication and psychotherapy are underway in each of these areas as part of a world-renowned research program; there is no charge to research participants.
Additional information is available via the following links:
